Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about IONS
Recent news which mentions IONS
< Previous
1
2
3
4
5
Next >
The Latest Analyst Ratings For Ionis Pharmaceuticals
April 09, 2024
Tickers
IONS
Tags
Benzinga
BZI/AAR
IONS
From
Benzinga
Genetic Medicines Focused-Ionis Pharmaceuticals' Fatty Liver Candidate Lowers Excess Liver Fat, Midstage Study Data Shows
March 13, 2024
Tickers
IONS
NEWS
Tags
Briefs
News
why it's moving
From
Benzinga
Cracking The Code: Understanding Analyst Reviews For Ionis Pharmaceuticals
February 22, 2024
Tickers
IONS
Tags
Benzinga
BZI/AAR
IONS
From
Benzinga
Earnings Scheduled For February 21, 2024
February 21, 2024
Tickers
ACVA
ADI
AGI
AGR
Tags
ROCK
MATV
TCOM
From
Benzinga
JP Morgan Maintains Neutral Rating for Ionis Pharmaceuticals: Here's What You Need To Know
February 01, 2024
Tickers
IONS
Tags
Benzinga
BZI/AAR/UPDATE
IONS
From
Benzinga
Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
January 31, 2024
Tickers
BIIB
IONS
NEWS
Tags
IONS
BIIB
General
From
Benzinga
Rare Disease Focused Ionis Pharmaceuticals Gears Up for FDA Submission After Donidalorsen Outperforms Placebo In Swollen Vessels Study
January 22, 2024
Tickers
IONS
NEWS
Tags
Reiteration
Expert Ideas
Analyst Color
From
Benzinga
Expert Outlook: Ionis Pharmaceuticals Through The Eyes Of 8 Analysts
January 18, 2024
Tickers
IONS
Tags
Benzinga
IONS
BZI/AAR
From
Benzinga
2024 And Beyond – Exploring Six Investment Megatrends With Tema ETFs
January 04, 2024
Tickers
ALNY
ARM
CPRI
IONS
Tags
SPGI
tema etfs
Benzinga
From
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 02, 2024
Tickers
ABBV
ALNY
CVS
GILD
Tags
IMGN
IONS
BZI/AUOA
From
Benzinga
3 Stocks to Buy Now Before They Become Tomorrow’s Trillion-Dollar Companies
December 27, 2023
Tickers
IONS
TSM
UNH
Tags
IONS
UNH
TSM
From
InvestorPlace
Pricing Projections And Market Potential For Ionis' Newly Approved Nerve Damage Drug - Analyst Sees Over $700M Potential
December 22, 2023
Tickers
ALNY
AZN
IONS
NEWS
Tags
Analyst Color
Expert Ideas
Reiteration
From
Benzinga
New Hope for Nerve Damage Patients as AstraZeneca/Ionis' Eplontersen Receives FDA Nod for Hereditary Amyloidosis Treatment
December 22, 2023
Tickers
AZN
IONS
NEWS
Tags
Benzinga
FDA
Trading Ideas
From
Benzinga
Ionis' Strategic Shift Praised by Analysts For Donidalorsen's Global Reach
December 19, 2023
Tickers
IONS
TAK
Tags
News
Briefs
General
From
Benzinga
Where Ionis Pharmaceuticals Stands With Analysts
November 17, 2023
Tickers
IONS
Tags
Analyst Ratings
Market News
Benzinga
From
Benzinga
Cathie Wood's Ark Invest Goes Shopping For Moderna Stock — Sells DraftKings Shares Amid Quarterly Rise In Revenue, EPS Beat
November 02, 2023
Tickers
ARKG
ARKK
ARKQ
DKNG
Tags
ETFs
Benzinga
ARKQ
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
October 23, 2023
Tickers
IONS
Tags
Analyst Ratings
Market News
IONS
From
Benzinga
Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On?
October 17, 2023
Tickers
ARKG
ARKK
CRSP
EVS
Tags
ETFs
Benzinga
electric vehicles
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
September 29, 2023
Tickers
ABBV
ADBE
ADSK
AKAM
Tags
IONS
INGR
Upgrades
From
Benzinga
Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges
September 27, 2023
Tickers
ALNY
AZN
IONS
NVS
Tags
ALNY
RHHBY
General
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
September 27, 2023
Tickers
IONS
Tags
Analyst Ratings
Market News
BZI/AAR
From
Benzinga
Why Ionis Pharmaceuticals Stock Popped Today
September 26, 2023
Tickers
IONS
Tags
Benzinga
Market News
IONS
From
Benzinga
Ionis Pharmaceuticals' Rare Metabolic Disorder Candidate Poised To Become New Standard Treatment, Study Shows Encouraging Action
September 26, 2023
Tickers
IONS
Tags
Movers
why it's moving
News
From
Benzinga
The 7 Most Hated Stocks by Institutional Traders
September 20, 2023
Tickers
GS
IONS
LLY
PDD
Tags
Market News
NASDAQ:PTON,NYSE:TOST,NASDAQ:IONS,NASDAQ:TMUS,NASDAQ:PDD,NYSE:GS,NYSE:LLY
TOST
From
InvestorPlace
Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope
September 07, 2023
Tickers
ALNY
IONS
RHHBF
RHHBY
Tags
Benzinga
Trading Ideas
Market News
From
Benzinga
Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports
August 07, 2023
Tickers
ACCD
ARKG
ARKK
ARKW
Tags
QSI
RXRX
News
From
Benzinga
Analyst Upgrades Ionis Pharmaceuticals To Buy Amid Key Pipeline Developments: Eplontersen And Donidalorsen Show Promising Outlook
July 31, 2023
Tickers
ALNY
AZN
IONS
Tags
General
ALNY
Upgrades
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
July 31, 2023
Tickers
A
ABR
ADBE
AIV
Tags
HAS
UPS
NTR
From
Benzinga
Apple To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Monday
July 31, 2023
Tickers
AAPL
ADBE
BAX
CMCSA
Tags
BAX
IONS
GTLS
From
Benzinga
Biogen Reports New Spinraza Data In Atrophy Patients After Incomplete Response To Novartis' Treatment
July 03, 2023
Tickers
BIIB
IONS
NVS
Tags
Analyst Ratings
Market News
Benzinga
From
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.